|
|
|
|
|
News and Articles on Race-based drug
Unfinished Race Aug 27, 2008
In the case of BiDil, they note, the manufacturer "is voluntarily financing a study to investigate the genetic basis for the response to the drug." But in general, "Once a race-based drug has been developed, there is a possibility that a drug company may terminate its research and not pursue follow-up studies into the underlying cause. This could stunt medical care with race-based medicine, rather than personalized medicine." Accordingly, they pass along a recommendation that the Food and Drug... (Slate)
Race, genes, and illness Apr 19, 2007
In 2005, regulators approved the first race-based drug, BiDil, for treating heart failure in black patients. Some pharmacologists have wondered whether race should affect prescription dosage, based on possible differences in drug metabolism. (Boston Globe)
Prejudicial treatment Apr 30, 2006
That history of racism in the United States, where most new drugs are developed and tested for the first time, is hampering the development of race-based drugs, the panel at BIO 2006 heard ... The first race-based drug to hit the market, BiDil, was approved by the U.S. Food and Drug Administration last June for use by black cardiac patients ... That's what makes race-based drugs so important, says Vanessa Northington Gamble, director of the Tuskegee University National Center for Bioethics in... (Toronto Star -- Life)
[ Terms Of Use | Privacy | About ]
©1998-2008 SurfWax, Inc.
All rights reserved. Patents pending.
|
|
|
Copyright SurfWax, Inc. 2008
|
|
